NCT00452686View on ClinicalTrials.gov

Study to Assess Safety & Immunogenicity of GSK Biologicals' Boostrix (dTpa) Vaccine vs. Chinese DT Vaccine

PHASE3CompletedINTERVENTIONAL
Enrollment

660

Participants

Timeline

Start Date

March 31, 2007

Study Completion Date

May 31, 2007

Conditions
DiphtheriaAcellular PertussisTetanus
Interventions
BIOLOGICAL

Boostrix

BIOLOGICAL

Chinese DT vaccine

Trial Locations (1)

Unknown

GSK Investigational Site, Suining

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY